Inventors at Stanford University have developed a light-based 3D printing system that achieves high printing resolutions and fast printing speeds with cell-compatible natural protein biomaterials when compared to existing methods.
This invention describes reinforced grafts made from biocompatible materials that are designed for use in surgical procedures such as coronary bypass graft surgery, vascular surgery, and arteriovenous fistula.
Researchers at Stanford University have formulated a novel biomaterial suitable for three-dimensional (3D) bioprinting: a homogeneous composite of polycaprolactone (PCL), gelatin, and beta-tricalcium phosphate.
Researchers at Stanford have developed a porous biologics-loaded multimaterial construct, called Hybrid Tissue Engineering Construct (HyTEC), with applications in regenerative medicine and therapeutic delivery.
Stanford scientists have invented a new suite of adaptable hydrogel biomaterials that are optically transparent and injectable for cell encapsulation, tissue engineering, and drug delivery.
Stanford researchers have constructed a microbial cell factory by genetically modifying the bacterium Methylomicrobium alcaliphilum 20Z to convert methanol and methane into para-hydroxybenzoic acid (p-HBA).
Current injectable hydrogel materials have fast erosion and limited tunability of their mechanical properties at different stages of applications, limiting their biomedical applications.
A team of Stanford researchers has developed a precisely controlled hydrogel drug delivery system that prevents scarring and promotes wound healing in large, full thickness wounds.
Researchers in Dr. Craig Criddle's lab have developed a method for enriching microorganisms with high poly(3-hydroxy)butyrate (PHB) production in non-sterile mixed culture conditions.
Researchers in Dr. Alfred Spormann's lab have developed a method of using co-cultures to enhance microbial electrosynthesis to allow more efficient production of desired products such as biofuel.
Researchers at Stanford have developed methods for preparing photo-, and chemical-, cross-linkable three-dimensional matrices for the controlled delivery of bioactive molecules for therapeutic applications.
Richard Zare's lab at Stanford University has developed a ground-breaking drug release system in which injected medication can be controlled externally with excellent spatial, temporal, and dosage control.
Stanford researchers developed a method to increase microbial fermentation gas transfer – a limiting factor in the production of bio products such as polyhydroxyalkanoates (PHAs).